share_log

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $17 Price Target

Benzinga ·  Aug 1, 2023 06:16

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $17 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment